Dengue and Zika: Control and Antiviral Treatment Strategies

This contributed volume contains 25 chapters from leading international scientists working on dengue and Zika viruses, who came together in Praia do Tofo in Mozambique to discuss the latest developments in the fields of epidemiology, pathogenesis, structural virology, immunology, antiviral drug disc...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Hilgenfeld, Rolf (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Vasudevan, Subhash G. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Singapore : Springer Singapore : Imprint: Springer, 2018.
Έκδοση:1st ed. 2018.
Σειρά:Advances in Experimental Medicine and Biology, 1062
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05180nam a2200469 4500
001 978-981-10-8727-1
003 DE-He213
005 20191022043550.0
007 cr nn 008mamaa
008 180529s2018 si | s |||| 0|eng d
020 |a 9789811087271  |9 978-981-10-8727-1 
024 7 |a 10.1007/978-981-10-8727-1  |2 doi 
040 |d GrThAP 
050 4 |a QR355-502 
072 7 |a MMFM  |2 bicssc 
072 7 |a MED052000  |2 bisacsh 
072 7 |a MKFM  |2 thema 
082 0 4 |a 616.9101  |2 23 
245 1 0 |a Dengue and Zika: Control and Antiviral Treatment Strategies  |h [electronic resource] /  |c edited by Rolf Hilgenfeld, Subhash G. Vasudevan. 
250 |a 1st ed. 2018. 
264 1 |a Singapore :  |b Springer Singapore :  |b Imprint: Springer,  |c 2018. 
300 |a XIII, 375 p. 99 illus., 70 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 1062 
505 0 |a Chapter 1. Arboviruses on the rise -- Chapter 2. Historical perspective of arboviruses in Mozambique and its implication for current and future epidemics -- Chapter 3. Reliable serological testing for the diagnosis of emerging infectious diseases -- Chapter 4. Flaviviral RNA structures and their role in replication and immunity -- Chapter 5. The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections -- Chapter 6. Structures of Zika virus E & NS1: relations with virus infection and host immune responses -- Chapter 7. Plugging the leak - is dengue a case of aseptic shock with NS1 at its center -- Chapter 8. Entry & NS1 as drug targets -- Chapter 9. The dengue virus replication complex: from RNA replication to protein-protein interactions to evasion of innate immunity -- Chapter 10. Crystal structure of Zika virus NS2B-NS3 protease -- Chapter 11. The transactions of NS3 and NS5 in Dengue viral RNA replication -- Chapter 12. Establishment and application of flavivirus replicons -- Chapter 13. Strategies towards protease inhibitors for emerging flaviviruses -- Chapter 14. Discovery of potent non-nucleoside inhibitors of dengue viral RNA-dependent RNA polymerase from fragment screening and structure-guided design -- Chapter 15. Nuclear cytoplasmic trafficking of dengue non-structural protein 5 as a target for antivirals -- Chapter 16. Animal Models for Dengue and Zika Vaccine Development -- Chapter 17 Understandingthe human T cell response to dengue virus -- Chapter 18. Regulation and function of NK and T cells during dengue virus infection and vaccination -- Chapter 19. Structural insights into the broad-spectrum antiviral target Endoplasmic Reticulum alpha glucosidase II -- Chapter 20. Mechanisms of antiviral activity of iminosugars against dengue virus -- Chapter 21. Countering Zika Virus: The USAMRIID Response -- Chapter 22 Dengue Antiviral Development: A Continuing Journey -- Chapter 23 An industry perspective on dengue drug discovery and development -- Chapter 24. The use of Wolbachia by the Eliminate Dengue program to interrupt transmission of Aedes Aegypti transmitted viruses -- Chapter 25 Seroepidemiological studies of Arboviruses in Africa. 
520 |a This contributed volume contains 25 chapters from leading international scientists working on dengue and Zika viruses, who came together in Praia do Tofo in Mozambique to discuss the latest developments in the fields of epidemiology, pathogenesis, structural virology, immunology, antiviral drug discovery and development, vaccine efficacy, and mosquito control programs. The meeting venue offered an opportunity to discuss current research on these flaviviruses in an idyllic setting, and also to develop first-hand appreciation of the issues in infectious diseases facing developing countries and of the research gaps in Africa. For readers, who should include basic and clinical researchers in the field and public health professionals, the chapters are organized to provide a comprehensive overview of the various topics in current dengue and Zika virus research. A unique feature of the proceedings of this meeting is the inclusion of the discussions that took place following presentations. These have been transcribed and appended to the end of the relevant chapters, and they form the "salt in the soup" of this book. 
650 0 |a Virology. 
650 1 4 |a Virology.  |0 http://scigraph.springernature.com/things/product-market-codes/B22003 
700 1 |a Hilgenfeld, Rolf.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Vasudevan, Subhash G.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9789811087264 
776 0 8 |i Printed edition:  |z 9789811087288 
776 0 8 |i Printed edition:  |z 9789811342257 
830 0 |a Advances in Experimental Medicine and Biology,  |x 0065-2598 ;  |v 1062 
856 4 0 |u https://doi.org/10.1007/978-981-10-8727-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)